Kymera TherapeuticsListed
kymeratx.combiotech_life_sciences
Kymera is a clinical-stage biotechnology company focused on developing innovative medicines through targeted protein degradation, aiming to address critical health problems and im…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Kymera is a clinical-stage biotechnology company focused on developing innovative medicines through targeted protein degradation, aiming to address critical health problems and im…
Editas Medicine is a pioneering gene editing company focused on developing transformative medicines using CRISPR technology to treat serious diseases.
Alnylam Pharmaceuticals is a leading company in the field of RNA interference (RNAi) therapeutics, focusing on the development of innovative medicines for genetic diseases.
Exelixis is a multi-platform cancer company innovating with small molecules and biotherapeutics to develop a diversified portfolio of cancer treatments.
Horizonte Therapeutics is a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for individuals affected by rar…
MorphoSys is a biotechnology company focused on developing innovative therapies. They have conducted research on MOR202 in combination with low-dose dexamethasone and continue to…
Generation Bio is a biotechnology company changing what is possible for people living with T cell-driven autoimmune diseases.
Harnessing breakthrough science to advance hematology care, focusing on innovative treatments for hematologic diseases.
A biotechnology company developing nucleic acid therapies for rare diseases.
Q32 Bio is focused on developing innovative therapies for autoimmune and inflammatory diseases, particularly targeting immune system rebalancing.
Sionna Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductanc…
Akero Therapeutics is focused on developing Efruxifermin (EFX) for the treatment of metabolic diseases, particularly MASH (Metabolic Associated Steatotic Liver Disease).
Judo Bio is pioneering oligonucleotide medicines delivered to the kidney, opening the way for new RNA medicines for systemic and renal diseases. With our STRIKE (Selectively Targe…
Kinaset Therapeutics is focused on developing inhaled therapeutics to address significant unmet medical needs in respiratory diseases. Their lead clinical candidate, frevecitinib…
Mariana Oncology, a Novartis company, is pioneering novel radioligand therapies designed to optimize cancer treatment efficacy while minimizing side effects for patients.
nChroma Bio is a genetic medicines company committed to addressing the limitations of existing therapies through a disease-first approach. By combining programmable in vivo delive…
Remix Therapeutics is advancing a new class of therapeutics by modulating RNA processing with small molecules. The company focuses on drug discovery programs that target previousl…
Renasant Bio is pioneering a new approach to treating autosomal dominant polycystic kidney disease (ADPKD) by developing small molecule correctors and potentiators that target the…
Nimbus Therapeutics is focused on developing breakthrough medicines through precision small molecule design, emphasizing selectivity in drug discovery and clinical development.
HotSpot Therapeutics is pioneering a new approach to allosteric drug discovery by unlocking the on/off switches on proteins called 'natural hotspots' to enable differentiated medi…
Antares Therapeutics is a biotechnology company developing transformational, first-in-class precision medicines with a focus on validated, undruggable targets in cancer and other…
TRIANA Biomedicines is a venture-backed biopharmaceutical company leading a transformative approach to discover and develop novel therapeutics to treat diseases. The company focus…
Lifordi is among the first companies to leverage the success of antibody-drug conjugates (ADC) in oncology to develop treatments for autoimmune and inflammatory disorders. They fo…
AAVantgarde is a clinical stage, biotechnology company advancing best-in-class therapies for patients with inherited retinal diseases (IRDs). With a strong foundation in translati…
Accent is leading the translation of RNA-modifying protein (RMP) biology into promising new therapies by combining a robust chemical biology platform with rigorous approaches to t…
Biotechnology company developing rationally designed AAV gene therapies for cardiovascular and neurological diseases. Its proprietary ART platform uses AI and structural modeling…
At Aiolos Bio, we are dedicated to revolutionizing the treatment landscape for respiratory disease and other immunological disorders. Our goal is to provide patients and caregiver…
Develops and produces etomidate-based anesthetic products designed not to affect breathing and blood pressure in the way other anesthetics may. Markets its products to anesthesiol…
Arkuda Therapeutics is a biotechnology company leveraging new insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative di…
Insufficient information in the provided search result to verify the company’s products, technology, or business model. The name suggests a therapeutics company, but this is not c…
Biotechnology company that developed targeted covalent drugs using a proprietary platform to irreversibly bind and silence disease-causing proteins. Its drug programs addressed di…
Bicycle Therapeutics is developing precision-guided therapeutics to target solid tumors and other hard-to-treat conditions using their proprietary phage display-screening platform.
Biopharmaceutical company developing small-molecule therapeutics for nervous system and neuropsychiatric disorders, including spinocerebellar ataxia and schizophrenia. Its clinica…
Cogent Biosciences is a biotechnology company focused on precision therapies for genetically defined diseases, particularly targeting KIT mutations in cancers like GIST and system…
Biopharmaceutical company developing an investigational siRNA medicine targeting sFlt1 for preterm preeclampsia, with the goal of reducing excess protein production and improving…
CoStim Pharmaceuticals is focused on developing breakthrough biotechnology solutions, particularly in the field of cancer treatment through immune checkpoint modulation.
Global biopharmaceutical company focused on discovering, developing, manufacturing, and marketing vaccines and antibody products, particularly for infectious diseases. Its portfol…
Day One Biopharmaceuticals is dedicated to developing targeted cancer therapies for children and adults, focusing on innovative drug development to provide new treatment options f…
Icelandic biopharmaceutical and human-genetics research company that uses population-scale genomic, medical, and genealogical data to identify genetic variants associated with com…
Delinia is a biotechnology company developing novel therapeutics for the treatment of autoimmune diseases. Delinia’s lead program is a molecule that potentiates and expands Regula…
Diagonal Therapeutics is a biotechnology company developing disease-modifying clustering antibodies that correct dysregulated signaling in severe genetic diseases, focusing on her…
Biotechnology company developing disease-modifying small-molecule therapeutics to prevent axonal degeneration in neurological diseases, including multiple sclerosis, amyotrophic l…
Developing best-in-class medicines to improve the lives of people with Thyroid Eye Disease and Graves’ Disease.
Biopharmaceutical company developing oncology solutions, including clinical testing for breast, gastric, and colorectal cancers.
Global platform-based biopharmaceutical company discovering and developing antibody therapeutics, with proprietary transgenic mouse, single B-cell cloning, bispecific and multispe…
Biopharmaceutical company focused on identifying, developing, acquiring, and commercializing differentiated medicines for unmet medical needs. It markets medicines across orphan d…
Biotechnology company developing first-in-class small-molecule medicines that precisely modulate the innate immune system to treat inflammation-driven diseases and cancer. Its pro…
Ikena Oncology is dedicated to redefining targeted oncology therapies with a mission to find cures for every cancer patient. They develop biomarker-driven targeted cancer therapie…
Intellia Therapeutics is a biotechnology company focused on using CRISPR technology for gene editing. The company is involved in developing treatments for genetic diseases.
Translating epigenetic modulation of oncogenic pathways into first-in-class small molecule therapeutics.
Kailera is an advanced clinical-stage biotechnology company focused on elevating the next era of obesity care by progressing a diversified pipeline to provide options for people l…
Korro Bio is focused on discovering, developing, and commercializing a new class of RNA therapies informed by human genetics and disease biology to improve the lives of patients w…
Biotechnology company developing therapies for neurodegenerative diseases, with a focus on GBA-associated parkinsonism. Its lead drug candidate, LTI-291, targets disease biology l…
Matchpoint Therapeutics is a biotechnology company pioneering the discovery of precision covalent medicines to transform the treatment of immune diseases. The company utilizes its…
Micromet Inc. develops innovative antibody-based therapies primarily for cancer treatment. The company’s core product is its proprietary BiTE (Bispecific T-cell Engager) platform,…
Biotechnology company focused on discovering and developing therapeutics, particularly for rare and immune-mediated diseases. Its proprietary technology analyzes and engineers com…
Novexel focused on developing antibiotics to treat resistant infections. The company is known for its research in the infection therapy area and has developed anti-infectives aime…
Obsidian Therapeutics is pioneering engineered TIL cell therapies using its proprietary cytoDRiVE® platform to improve outcomes for patients with solid tumor malignancies.
Private Cambridge, Massachusetts biotechnology company developing medicines that target protein-arginine deiminase (PAD) enzymes, with the goal of treating destructive autoimmune…
Pheon Therapeutics is a leading Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide range of hard-to-treat cancers.
Biotechnology company developing oral small-molecule Positive Functional Modulators (PFMs) that restore or enhance dysfunctional membrane protein activity. Its platform targets AB…
Replimune is a biotech company focused on revolutionizing cancer treatment with a new class of oncolytic immunotherapies intended to activate a powerful and durable full-body anti…
Rodin Therapeutics is a biotechnology research company focused on epigenetic regulation of neuronal function to treat brain diseases. It pursues targeted epigenetic regulation thr…
Scorpion is a clinical-stage, precision oncology company developing transformational targeted therapies for patients with cancer. We have built proprietary and fully-integrated di…
Spero Therapeutics is a clinical-stage biopharmaceutical company advancing innovative medicines for immune-mediated diseases, beginning with SP001, a third-generation anti-CD40L a…
Stromedix LLC develops antibody drugs targeting fibrotic organ failure, with anti-fibrotic activity demonstrated in preclinical models of lung, kidney, and liver diseases.
Cambridge-based immuno-oncology biotechnology company that developed next-generation antibody therapies targeting the tumor microenvironment for cancer treatment, including progra…
Synlogic Therapeutics develops engineered living biotherapeutics, called Synthetic Biotics, using synthetic biology to program microorganisms to address underlying drivers of dise…
Third Harmonic Bio is a clinical-stage biopharmaceutical company developing a highly selective, oral KIT inhibitor for treatment of dermal, respiratory and gastrointestinal inflam…
Biopharmaceutical company developing genomic medicines for neurodegenerative diseases, initially targeting ALS. Its lead antisense oligonucleotide program aims to correct UNC13A m…
Details are not available yet. The company remains listed.
Clinical-stage biotechnology company developing genetics-informed precision antibody therapeutics for immune and inflammatory diseases. It combines human genetics, mechanistic bio…
Biotechnology company developing treatments for obesity and cardiometabolic diseases. Its research targets activin type II receptors and combines activin biology with incretin bio…
Vitae Pharmaceuticals was a biotechnology company focused on discovering and developing small-molecule therapeutics for serious diseases, including inflammatory and autoimmune dis…